Academic hospital staff compliance with a fecal immunochemical test-based colorectal cancer screening program

被引:0
|
作者
Vlachonikolou, Georgia [1 ,2 ]
Gkolfakis, Paraskevas [1 ,2 ]
Sioulas, Athanasios D. [1 ,2 ]
Papanikolaou, Ioannis S. [1 ,2 ]
Melissaratou, Anastasia [1 ,2 ]
Moustafa, Giannis-Aimant [1 ,2 ]
Xanthopoulou, Eleni [1 ,2 ]
Tsilimidos, Gerasimos [1 ,2 ]
Tsironi, Ioanna [1 ,2 ]
Filippidis, Paraskevas [1 ,2 ]
Malli, Chrysoula [1 ,2 ]
Dimitriadis, George D. [1 ,2 ]
Triantafyllou, Konstantinos [1 ,2 ]
机构
[1] Univ Athens, Hepatogastroenterol Unit, Dept Internal Med 2, Attikon Univ Gen Hosp,Med Sch, 1 Rimini St, Athens 12462, Greece
[2] Univ Athens, Res Inst, Attikon Univ Gen Hosp, Sch Med, 1 Rimini St, Athens 12462, Greece
关键词
Colorectal cancer; Screening; Academic hospital staff; Fecal immunochemical test; Compliance; GUIDELINE;
D O I
10.4251/wjgo.v8.i8.629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM: To measure the compliance of an Academic Hospital staff with a colorectal cancer (CRC) screening program using fecal immunochemical test (FIT). METHODS: All employees of " Attikon" University General Hospital aged over 50 years were thoroughly informed by a team of physicians and medical students about the study aims and they were invited to undergo CRC screening using two rounds of FIT (DyoniFOB (R) Combo H, DyonMed SA, Athens, Greece). The tests were provided for free and subjects tested positive were subsequently referred for colonoscopy. One year after completing the two rounds, participants were asked to be re-screened by means of the same test. RESULTS: Among our target population consisted of 211 employees, 59 (27.9%) consented to participate, but only 41 (19.4%) and 24 (11.4%) completed the first and the second FIT round, respectively. Female gender was significantly associated with higher initial participation (P = 0.005) and test completion -first and second round - (P = 0.004 and P = 0.05) rates, respectively. Phy sician's (13.5% vs 70.2%, P < 0.0001) participation and test completion rates (7.5% vs 57.6%, P < 0.0001 for the first and 2.3% vs 34%, P < 0.0001 for the second round) were significantly lower compared to those of the administrative/technical staff. Similarly, nurses participated (25.8% vs 70.2%, P = 0.0002) and completed the first test round (19.3% vs 57.6%, P = 0.004) in a significant lower rate than the administrative/technical staff. One test proved false positive. No participant repeated the test one year later. CONCLUSION: Despite the well-organized, guided and supervised provision of the service, the compliance of the Academic Hospital personnel with a FIT-based CRC screening program was suboptimal, especially among physicians.
引用
收藏
页码:629 / 634
页数:6
相关论文
共 50 条
  • [31] Colorectal Cancer Screening: Fecal immunochemical Test or Sigmoidoscopy?
    Hofmann-Assmus, Marion
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (07): : 626 - 628
  • [32] CHRONOLOGICAL TREND OF COLONOSCOPY KEY QUALITY INDICATORS AND INCIDENCE OF POST-COLONOSCOPY COLORECTAL CANCER IN FECAL IMMUNOCHEMICAL TEST-BASED SCREENING PROGRAM IN TAIWAN
    Chiu, Han-Mo
    Su, Chiu-Wen
    Hsu, Wen-Feng
    Lee, Yi-Chia
    Chang, Li-Chun
    Lin, Li-Ju
    Wu, Ming-Shiang
    GASTROENTEROLOGY, 2021, 160 (06) : S31 - S31
  • [33] Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
    Joanne M. Osborne
    Carlene Wilson
    Amy Duncan
    Stephen R. Cole
    Ingrid Flight
    Deborah Turnbull
    Donna L. Hughes
    Graeme P. Young
    BMC Public Health, 18
  • [34] Risk prediction for advanced neoplasia using longitudinal adherence measures to fecal immunochemical test-based colorectal cancer screening programs
    de Jonge, L.
    Riggi, Emilia
    van Duuren, Luuk A.
    Toes-Zoutendijk, Esther
    Campari, Cinzia
    Sassatelli, Romano
    Arrigoni, Arrigo
    Orione, Lorenzo
    Lansdorp-Vogelaar, Iris
    Senore, Carlo
    PREVENTIVE MEDICINE, 2023, 170
  • [35] RISK PREDICTION FOR ADVANCED NEOPLASIA USING LONGITUDINAL ADHERENCE MEASURES TO FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAMS
    De Jonge, Lucie
    Riggi, Emilia
    van Duuren, Luuk
    Toes-Zoutendijk, Esther
    Campari, Cinzia
    Sassattelli, Romano
    Arrigoni, Arrigo
    Orione, Lorenzo
    Lansdorp-Vogelaar, Iris
    Senore, Carlo
    GASTROENTEROLOGY, 2022, 162 (07) : S878 - S878
  • [36] Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
    Osborne, Joanne M.
    Wilson, Carlene
    Duncan, Amy
    Cole, Stephen R.
    Flight, Ingrid
    Turnbull, Deborah
    Hughes, Donna L.
    Young, Graeme P.
    BMC PUBLIC HEALTH, 2017, 18
  • [37] Time to Fecal Immunochemical Test Completion for Colorectal Cancer Screening
    Haas, Cameron B.
    Phipps, Amanda I.
    Hajat, Anjum
    Chubak, Jessica
    Wernli, Karen J.
    AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (04): : 174 - +
  • [38] Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death
    Doubeni, Chyke A.
    Corley, Douglas A.
    Jensen, Christopher D.
    Levin, Theodore R.
    Ghai, Nirupa R.
    Cannavale, Kimberly
    Zhao, Wei K.
    Selby, Kevin
    Buckner-Petty, Skye
    Zauber, Ann G.
    Fletcher, Robert H.
    Weiss, Noel S.
    Schottinger, Joanne E.
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [39] Efficacy of a computer-aided detection system in a fecal immunochemical test-based organized colorectal cancer screening program: a randomized controlled trial (AIFIT study)
    Rondonotti, Emanuele
    Di Paolo, Dhanai
    Rizzotto, Erik Rosa
    Alvisi, Costanza
    Buscarini, Elisabetta
    Spadaccini, Marco
    Tamanini, Giacomo
    Paggi, Silvia
    Amato, Arnaldo
    Scardino, Giulia
    Romeo, Samanta
    Alicante, Saverio
    Ancona, Fabio
    Guido, Ennio
    Marzo, Vincenza
    Chicco, Fabio
    Agazzi, Simona
    Rosa, Cesare
    Correale, Loredana
    Repici, Alessandro
    Hassan, Cesare
    Radaelli, Franco
    ENDOSCOPY, 2022, 54 (12) : 1171 - 1179
  • [40] Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening
    Gies, Anton
    Cuk, Katarina
    Schrotz-King, Petra
    Brenner, Hermann
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (08) : 1223 - 1231